Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bairui granules for acute bronchitis
ChiCTR2200063906Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Bairui granules in acute bronchitis (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Rate of cough resolution after 7 days of treatment. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
Bairui granules
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on ChiCTR2200063906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063906.